May 31, 2017

Meet the investors in Android founder's new smartphone startup

Andy Rubin's startup, Essential unveiled its new smartphone earlier in the day, but has been mum on who is providing the significant funding needed to build a big new consumer electronics company. However, a slide on the company's Web site appears to answer the question.

In the investor section of Essential's new Web page, the company lists the logos of contract manufacturer Foxconn, Rubin's incubator Playground, Redpoint, Access Technology Ventures, Tencent, VY Capital and Altimeter Capital. Essential officials had declined to comment earlier in the day on the amount of funding it had raised or who had invested.

The Wall Street Journal reported earlier this year that SoftBank had pulled back on plans to invest in Essential.

Rubin is set to talk more about his vision for Essential, which stretches far beyond the phone, in an appearance shortly at Code Conference.

Why it matters: Essential has talked about wanting to build not just a couple products, but a big new consumer electronics brand. That's going to take some serious money.

Update: On stage at Code Conference, Rubin confirmed the company began with a $30 million round from Playground and Redpoint, and has raised a second round of financing, with total financing in the "hundreds of millions" of dollars. He also confirmed that SoftBank had been all set to invest, but said a conflict arose due to a large investor in SoftBank's Vision Fund (aka Apple), which didn't want to back Essential, nor did Rubin want them having a stake.

Screenshot by Axios

Go deeper

Coronavirus stress tests drug industry's dependence on China

A Hong Kong commuter wears a face mask. Photo: Miguel Candela/SOPA Images/LightRocket via Getty Images

It's unclear whether the rapid spread of the novel coronavirus will actually result in prescription drug shortages, but it has undoubtedly highlighted the potential vulnerabilities of having the supply chain for American drugs so dependent on China.

Driving the news: About 150 prescription drugs — including antibiotics, generics and some branded drugs without alternatives — are at risk of shortage if the coronavirus outbreak in China worsens, per two sources familiar with a list of at-risk drugs compiled by the Food and Drug Administration.

Go deeperArrow26 mins ago - Health

Bernie's path to the presidency

Sen. Bernie Sanders speaks yesterday during a rally at Houston University. Photo: Mark Felix/AFP via Getty Images

Lots of Democrats are in full panic that Bernie Sanders will win the nomination and get clobbered in the general election — and bring the party down, too. But the evidence, particularly the polling, doesn't back those doomsday warnings.

Why it matters: Virtually every national and swing state poll shows Sanders tied with or beating President Trump.  And, unlike every rival, he has a huge base of fervent, unshakable supporters he can only grow.

These swing voters don't like Trump’s environmental rollbacks

Illustration: Sarah Grillo/Axios

Swing voters in four battleground states decisively oppose President Trump’s sweeping rollbacks of environmental regulations — but it’s unlikely to sway their votes.

Why it matters: It’s voters living in states like these, including Florida and Pennsylvania, who fill pivotal roles electing America’s presidents, so we should listen.